Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer's disease drug development pipeline: 2024
Jeffrey L. Cummings, Yadi Zhou, Garam Lee, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2024) Vol. 10, Iss. 2
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Zooming in on brain inflammation in Alzheimer’s disease
Wiesje M. van der Flier, Michael T. Heneka
Brain (2025) Vol. 148, Iss. 1, pp. 1-2
Closed Access | Times Cited: 1
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2024 Update
Kevin McFarthing, Sue Buff, Gary Rafaloff, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 5, pp. 899-912
Open Access | Times Cited: 12
Artificial intelligence for drug discovery and development in Alzheimer's disease
Yunguang Qiu, Feixiong Cheng
Current Opinion in Structural Biology (2024) Vol. 85, pp. 102776-102776
Open Access | Times Cited: 11
Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways
Oliwia Koszła, Przemysław Sołek
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Tracking neuroinflammatory biomarkers in Alzheimer’s disease: a strategy for individualized therapeutic approaches?
Simone Lista, Bruno P. Imbimbo, Margherita Grasso, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Taming neuroinflammation in Alzheimer's disease: The protective role of phytochemicals through the gut−brain axis
Yoonsu Kim, Jinkyu Lim, Jisun Oh
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117277-117277
Closed Access | Times Cited: 9
The associations of serum vitamin D status and vitamin D supplements use with all-cause dementia, Alzheimer’s disease, and vascular dementia: a UK Biobank based prospective cohort study
Li‐Ju Chen, Sha Sha, Hannah Stocker, et al.
American Journal of Clinical Nutrition (2024) Vol. 119, Iss. 4, pp. 1052-1064
Open Access | Times Cited: 7
Alzheimer’s Disease: Combination Therapies and Clinical Trials for Combination Therapy Development
Jeffrey L. Cummings, Amanda M. Leisgang Osse, Jefferson W. Kinney, et al.
CNS Drugs (2024) Vol. 38, Iss. 8, pp. 613-624
Open Access | Times Cited: 6
Targeting Microglia in Alzheimer’s Disease: Pathogenesis and Potential Therapeutic Strategies
Zhongqing Sun, Xin Zhang, Kwok‐Fai So, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 833-833
Open Access | Times Cited: 5
Drugs repurposing in the experimental models of Alzheimer’s disease
Sheer A. Joodi, Weam W. Ibrahim, Mahmoud M. Khattab
Inflammopharmacology (2025)
Open Access
Calcium signaling hypothesis: A non-negligible pathogenesis in Alzheimer’s disease
Minghui Wang, Hu Zhang, Jiling Liang, et al.
Journal of Advanced Research (2025)
Open Access
Gut microbiota in Alzheimer’s disease: Understanding molecular pathways and potential therapeutic perspectives
Simone Lista, Antonio Munafò, Filippo Caraci, et al.
Ageing Research Reviews (2025) Vol. 104, pp. 102659-102659
Closed Access
Expert opinion on Centiloid thresholds suitable for initiating anti-amyloid therapy. Summary of discussion at the 2024 spring Alzheimer's Association Research Roundtable
Gill Farrar, Christopher J. Weber, Gil D. Rabinovici
The Journal of Prevention of Alzheimer s Disease (2025) Vol. 12, Iss. 1, pp. 100008-100008
Open Access
Key considerations for combination therapy in Alzheimer's clinical trials: Perspectives from an expert advisory board convened by the Alzheimer's drug discovery foundation
Jeffrey Cummings, Michael Gold, Mark Mintun, et al.
The Journal of Prevention of Alzheimer s Disease (2025) Vol. 12, Iss. 1, pp. 100001-100001
Open Access
The Missing Link in Antiamyloid Therapy
Pravat K. Mandal, Joseph C. Maroon, Rimil Guha Roy, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Co-occurrence of neuropsychiatric symptoms in ADAMS, ADNI and NACC studies as assessed by Neuropsychiatric Inventory
Т. Л. Галанкин, Jina Swartz, Hans J. Moebius, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Fluorescence Imaging of Homocysteine Dynamics: Complementary Diagnostic Applications in Alzheimer's Disease
Guoxing Yin, Yitong Sun, Yufeng Luo, et al.
Analytica Chimica Acta (2025) Vol. 1342, pp. 343688-343688
Closed Access
Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer’s Disease
Eunshil Lee, Yongmin Chang
Cells (2025) Vol. 14, Iss. 3, pp. 168-168
Open Access
Effects of blood-brain barrier opening using ultrasound on tauopathies: A systematic review
Amandine Géraudie, Pierre De Rossi, Michael Canney, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 1029-1044
Open Access
Chimeric Antigen Receptors Discriminate Between Tau and Distinct Amyloid-Beta Species
Cynthia J. Siebrand, Nicholas J. Bergo, Suckwon Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Development of novel rivastigmine derivatives as selective BuChE inhibitors for the treatment of AD
Yuting Li, Qiyao Zhang, Xinxin Wang, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108245-108245
Closed Access
Mitochondrial Alterations, Oxidative Stress, and Therapeutic Implications in Alzheimer’s Disease: A Narrative Review
Erica Spina, Riccardo Rocco Ferrari, Elisa Pellegrini, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 229-229
Open Access
Discovery of structurally intriguing diterpenoids as anti-neuroinflammatory agents from mangrove plant Excoecaria agallocha L. via inhibiting macrophage polarization and inflammasome
Junyi Li, Mingbin Chen, Tingting Fu, et al.
Phytochemistry (2025), pp. 114440-114440
Closed Access
Microglial NLRP3 Inflammasomes in Alzheimer’s Disease Pathogenesis: From Interaction with Autophagy/Mitophagy to Therapeutics
Gunel Ayyubova, Leelavathi N. Madhu
Molecular Neurobiology (2025)
Closed Access
Page 1 - Next Page

Scroll to top